Unjha Formulations Ltd
Incorporated in 1991, Unjha Formulations Ltd is a manufacturer and exporter of psyllium husk-based products.[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit |
Ratios
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
|---|---|---|---|---|---|
| Export Sales USD ・Standalone data |
|
||||
| Ayurvedic Items Share of Total Turnover % ・Standalone data |
|||||
| Permanent Employees employees ・Standalone data |
|||||
| Production Volume - Powder (Isabgol based) kg ・Standalone data |
|||||
| Capacity Utilization - Powder (Isabgol based) % ・Standalone data |
|||||
Extracted by Screener AI
Documents
Announcements
-
Board Meeting Intimation for Board Meeting - Date: 05.11.2026 (Un-Audited Financial Results For The Half Year And Quarter Ended On 30.09.2026)
- Board meeting on 5 Nov 2026 to consider unaudited results for quarter and half year ended 30 Sep 2026.
-
Board Meeting Intimation for Board Meeting - Date: 05.11.2026 (Un-Audited Financial Results For The Half Year And Quarter Ended On 30.09.2026)
- Board meeting on 5 Nov 2026 to consider unaudited results for half year and quarter ended 30 Sep 2026.
-
Reguation 40(9) ,Compliance Report For Six Month Ended As On 30.09.2026
- Regulation 40(9) certificate confirms timely share transfers for six months ended 30.09.2026; no duplicate certificates requested.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Submissions Of XML File For Financial Statement I.E. Balance Sheet , P&L Accounts And Cash Flow Statement As On 31.03.2026 (AGM Held On 14/08/2026) As Per SEBI (Listing Obligation And Disclosure Requirements) Regulations,2015
- Submitted XML financial statements for 31.03.2026 after AGM held on 14/08/2026.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
-
Annual Report 2011
from bse
Business Overview:[1]
UFL is a part of M/s Urvesh Ltd. It is a GMP-certified manufacturer and exporter of Isabgol (Psyllium) and Ayurvedic formulation products.
The company also manufactures all kinds of small-volume Ayurvedic Isabgol (Psyllium) powder.